glp-1 agonist dementia Could diabetes and weight loss drugs treat Alzheimer's disease? GLP-1 Receptor Agonists Linked to

doi: 10.3390/ijms232314631, Summary Keywords GLP-1/GIP dual agonist, metabolic regulation, obesity, obstructive sleep apnea, tirzepatide Citation Fang Q, Zhu Y, Rao M and Liu P (2026) GLP-1/GIP dual agonist tirzepatide in obstructive sleep apnea syndrome: mechanisms, evidence, and clinical perspectives

We are encouraged by the weight loss outcomes associated with CagriSema, which show superiority over both semaglutide and cagrilintide in monotherapy in the REDEFINE 1 trial

Registries and post-marketing studies continue to expand our understanding of chronic GLP-1 use

Recent DSIP research has started shifting toward antioxidant biology